Levodopa + benserazide
Co-beneldopa
Brand names: Madopar
Adult dose
Dose: Initial 50mg levodopa TDS with food; titrate by 100mg every 3–4 days; usual maintenance 400–800mg/day in divided doses
Route: PO
Frequency: divided
Clinical pearls
- Idiopathic Parkinson's
- Never stop abruptly — risk of NMS-like syndrome
- Warn about impulse-control disorders
Contraindications
- Closed-angle glaucoma
- Severe psychiatric disease
- Phaeochromocytoma
- Concurrent non-selective MAOI
Side effects
- Nausea
- Postural hypotension
- Dyskinesias
- On-off phenomena
- Hallucinations
- Impulse control disorder
- Sleep attacks
Interactions
- Iron/protein meals reduce absorption
- MAOIs (hypertensive crisis)
- Antipsychotics (antagonism)
Monitoring
- BP
- Mental state
- Skin checks (melanoma)
Reference: BNF; NICE NG71; https://bnf.nice.org.uk/drugs/co-beneldopa/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS